Ординатура / Офтальмология / Учебные материалы / Manual of Eye Emergencies Diagnosis and Management Webb Kanski 2004
.pdf
208 Index
Pupils
afferent pupillary defect (APD) see Afferent pupillary defect (APD)
blunt injuries, 119 dilated, 67
treatment for, 190, 196 distorted, 119, 127, 128 examination, 7, 47, 66 and iris, 119
and nerve palsy (3rd), 110 painful eye, 66
red eye, 21, 47, 56, 60 small (miosis), 195
PVD (posterior vitreous detachment) see Posterior vitreous detachment (PVD)
Ranitidine, 54, 75
Rapitil (nedocromil sodium) drops, allergies, 50, 188, 195
RD (retinal detachment) see Retinal detachment (RD)
Reading glasses, 4, 72, 175 Red eye, 13–63
see also Painful eye; Watering eye acute onset, 17–62
allergy, 14, 16 bilateral, 45–55, 59–63
blepharitis see Blepharitis carotico-cavernous fistula, 54–5 chronic, 62–3
chronic, unilateral and bilateral, 62–3
conjunctivitis, 13, 14, 51–2, 56–7 contact lenses, 19, 35–8, 39, 45,
49–50, 62
corneal abrasion, 13, 15, 19, 21, 24–7 corneal foreign body, 13, 14, 18,
27–31
corneal ulcer, 17, 38–41 disease categories, 13–17
dysthyroid eye disease, 45, 46, 53–4 episcleritis/scleritis, 41–3, 42, 58–9 glaucoma, 41
ingrowing lashes/entropion, 14, 15, 33–4
onset, 13 painful, 17–55 painless, 55–62
shingles, 43–5, 150
subconjunctival hemorrhage, 14, 16, 17, 55, 57–8
subtarsal foreign body (STFB), 31, 32 trauma, 17, 19, 55
unilateral, 17–45, 55–9, 62–3 uveitis see uveitis (red eye)
viral keratoconjunctivitis, 52–3 welding/ grinding/ flash burn
injuries, 48–9 Red reflex, 7, 8
lens, sharp/penetrating injury to, 128
Retina
see also fundus (retina) central, 8
double vision, 109 peripheral, 8 tumors, 166–7
Retinal detachment (RD) associations, 86 examination/management, 86–7 features, 86
photopsia, 106, 107 pitfall, 88 referral/follow up, 87–8 surgery, 183
basic steps, 182 complications, 182 drops, 193 management, 182–4
vision loss, 86–8 Retinal hemorrhages, 81 Retinoblastoma, 8, 167
Retinopathy(diabetic patients), 70, 100–1, 103
Rimexolone (Vexol), 188 Rosacea, 38
Safety goggles, 130 Sclera/scleritis, 22, 24, 42, 56, 58–9,
60 examination, 6, 48 features, 41 management, 43
referral/follow up, 43 Sebaceous cell carcinoma, 153, 162 Sebaceous cyst, 160
Sessile papilloma, 159
Sharp and penetrating injuries, 120,
126
see also Blunt injuries examination, 128–9 gardening, 127, 129
glass injuries, 125, 127, 129 questions, asking, 127 thrown objects, 127, 129 usual causes, 125, 127 x-ray, 128
Shingles, 43–5, 65
eyelid infections, 149–50 Short sightedness (myopia), 175
Shuttlecocks, injuries caused by, 115
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Index |
|
|
209 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sinusitis, 65, 67–8 |
|
Sumatriptan, migraine treatment, 68 |
|
|
||||||||||||||||||||||
|
|
|
|
|
|
||||||||||||||||||||||||
|
|
|
|
|
|
||||||||||||||||||||||||
|
|
|
|
|
|
||||||||||||||||||||||||
|
|
|
|
eyelid infections, 147 |
|
Surgery, 170–85 |
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|||||||||||||||||||||||
|
|
|
Slit lamp |
|
|
see also Surgery complications |
|
|
|||||||||||||||||||||
|
|
|
|
basic examination, 11, 12 |
|
|
cataract, 170–4 |
|
|
||||||||||||||||||||
|
|
|
|
cataracts, 94 |
|
|
|
complications, 172–4 |
|
|
|||||||||||||||||||
|
|
|
|
conjunctivitis, 51, 59 |
|
|
|
drops, 192 |
|
|
|||||||||||||||||||
|
|
|
|
lost contact lenses, 37, 141 |
|
|
|
extracapsular lens extraction, |
|
|
|||||||||||||||||||
|
|
|
Smoking, 65, 73 |
172 |
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
|
|
Snellen chart, 2 |
|
|
|
following, 101–2, 184–5 |
|
|
||||||||||||||||||||
|
|
|
Sno Phenicol (antibiotic drops), 186 |
|
|
|
phacoemulsification, 170, 171, |
|
|
||||||||||||||||||||
|
|
|
Sodium cromoglicate, 188 |
172 |
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
|
|
SOL (space-occupying lesion), 104–5 |
|
|
|
sutures, 173 |
|
|
||||||||||||||||||||
|
|
|
|
|
|
|
|
||||||||||||||||||||||
|
|
|
Spectacles |
|
|
laser (excimer) refractive, 175–8 |
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|||||||||||||||||||||||
|
|
|
|
incorrect/absent, 65, 71–2 |
|
|
|
drops, 193 |
|
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
|
|
|
old, 65, 102–3 |
|
|
|
laser-assisted in situ |
|
|
|||||||||||||||||||
|
|
|
|
reading glasses, 4, 72, 175 |
|
|
|
keratomileusis (LASIK), 175–6 |
|
|
|||||||||||||||||||
|
|
|
|
visual acuity tests (VA), 2 |
|
|
|
photo refractive keratectomy |
|
|
|||||||||||||||||||
|
|
|
|
reading chart, 4 |
|
|
|
(PRK), 175, 176–8 |
|
|
|||||||||||||||||||
|
|
|
Squamous cell carcinoma, 161, 162 |
|
|
laser treatment, 184–5 |
|
|
|||||||||||||||||||||
|
|
|
Squash balls, injuries caused by, 115 |
|
|
|
cataract surgery, following, |
|
|
||||||||||||||||||||
|
|
|
Squint surgery, 179 |
|
|
|
184–5 |
|
|
||||||||||||||||||||
|
|
|
|
basic steps, 178–9 |
|
|
|
diabetics, 184 |
|
|
|||||||||||||||||||
|
|
|
|
complications, 180 |
|
|
|
glaucoma, 184 |
|
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
|
|
|
drops, 193 |
|
|
|
laser (excimer) refractive, 175–8, |
|
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
|
|
|
management, 180 |
193 |
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
|
|
Stemetil (antiemetic), glaucoma |
|
|
oculoplastic/trauma, 174–5 |
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|||||||||||||||||||||||
|
|
|
|
|
treatment, 41 |
|
|
previous, red eye, 17, 18, 19 |
|
|
|||||||||||||||||||
|
|
|
Steristrips, entropion, 34, 151 |
|
|
retinal detachment, 183 |
|
|
|||||||||||||||||||||
|
|
|
Steroid drops, 194–5 |
|
|
|
basic steps, 182 |
|
|
||||||||||||||||||||
|
|
|
|
allergies, 50 |
|
|
|
complications, 182 |
|
|
|||||||||||||||||||
|
|
|
|
episcleritis, 43 |
|
|
|
drops, 193 |
|
|
|||||||||||||||||||
|
|
|
|
uveitis, 35 |
|
|
|
management, 182–4 |
|
|
|||||||||||||||||||
|
|
|
Steroids, oral, temporal arteritis |
|
|
squint, 179 |
|
|
|||||||||||||||||||||
|
|
|
|
|
treatment, 75 |
|
|
|
basic steps, 178–9 |
|
|
||||||||||||||||||
|
|
|
STFB (subtarsal foreign body) see |
|
|
|
complications, 180 |
|
|
||||||||||||||||||||
|
|
|
|
|
|
|
|
||||||||||||||||||||||
|
|
|
|
|
Subtarsal foreign body (STFB) |
|
|
|
drops, 193 |
|
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
|
|
Styes, 65, 146, 147, 154, 156–7 |
|
|
|
management, 180 |
|
|
||||||||||||||||||||
|
|
|
|
|
|
|
|
||||||||||||||||||||||
|
|
|
Subarachnoid hemorrhage, occipital |
|
|
trabeculectomy (glaucoma), 181 |
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|||||||||||||||||||||||
|
|
|
|
|
pain, 69 |
|
|
|
basic steps, 180 |
|
|
||||||||||||||||||
|
|
|
Subconjunctival hemorrhage |
|
|
|
complications, 181 |
|
|
||||||||||||||||||||
|
|
|
|
blunt injuries, 118 |
|
|
|
drops, 192 |
|
|
|||||||||||||||||||
|
|
|
|
features, 57 |
|
|
|
management, 182 |
|
|
|||||||||||||||||||
|
|
|
|
management, 57, 123 |
|
Surgery complications |
|
|
|||||||||||||||||||||
|
|
|
|
pitfall, 57–8 |
|
|
see also Surgery |
|
|
||||||||||||||||||||
|
|
|
|
red eye, 14, 16, 17, 55 |
|
|
cataracts |
|
|
||||||||||||||||||||
|
|
|
|
referral/follow up, 57, 123 |
|
|
|
immediate (0-2) days, 172 |
|
|
|||||||||||||||||||
|
|
|
|
sharp/penetrating injuries, 128 |
|
|
|
early (2-7 days), 172–3 |
|
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
|
|
Submacular hemorrhage, macular |
|
|
|
late (7 days+), 173 |
|
|
||||||||||||||||||||
|
|
|
|
|
|
|
|
||||||||||||||||||||||
|
|
|
|
|
degeneration, 98 |
|
|
|
management, 173–4 |
|
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
|
|
Subnormal vision |
|
|
laser-assisted in situ keratomileusis |
|
|
|||||||||||||||||||||
|
|
|
|
see also Diplopia (double vision); |
|
|
|
(LASIK), 176 |
|
|
|||||||||||||||||||
|
|
|
|
|
Vision |
|
|
oculoplastic/trauma, 174 |
|
|
|||||||||||||||||||
|
|
|
|
basic examination, 4, 5 |
|
|
photo refractive keractomy (PRK), |
|
|
||||||||||||||||||||
|
|
|
|
red eye, 20 |
|
|
|
177–8 |
|
|
|||||||||||||||||||
|
|
|
Subtarsal foreign body (STFB), 31, |
|
|
squint surgery, 180 |
|
|
|||||||||||||||||||||
|
|
|
32 |
|
|
|
|
|
|
|
|
|
|
trabeculectomy (glaucoma), 181 |
|
|
|||||||||||||
|
|
|
|
corneal abrasions, 21 |
|
Sutures, cataract surgery, 173 |
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
210 Index
Tears
artificial, 190, 193, 196 ectropion, effect on, 134
normal production/drainage, 135 Tears Naturelle, 190, 196
Temporal arteritis, 64, 67, 74–5, 78 TENS (transcutaneous nerve
stimulation), 70, 149 Tetracaine hydrochloride see
Amethocaine (local anesthetic) Tetracyline ointment, conjunctivitis, 51 Thermal burns, laser treatment, 184 Thrown objects, 127, 129
Thyroid eye disease
see also Dysthyroid eye disease diplopia (double vision), 109, 111 red eye, 45, 59, 62
Timoptol/timolol (beta blocker), 195 allergies, 50
glaucoma, 189 shingles, 44
Tonopen, 81
Trabeculectomy (glaucoma surgery),
181
basic steps, 180 complications, 181 drops, 192 management, 182
Transcutaneous nerve stimulation (TENS), 70, 149
Trauma, 112–31
blunt injuries, 114–20 chemicalinjury, 13, 45, 112–14 chiselling injuries, 129–31 double vision, 123
fracture, ’blow-out’, 116, 121, 123 gardening injuries, 127, 129 glass injuries, 125, 127, 129 globe rupture, 17, 114, 118, 120 hammering injuries, 129–31 hyphema, 123–4
lid lacerations, 124–5 orbital bruising, 123 orbital hematoma
no view of eye, 121 with view of eye, 122
penetrating/sharp injuries, 18, 120, 125, 126, 127–9
red eye, 17, 19, 55 subconjuctival hemorrhage, 123 surgery, 174–5
thrown objects, 127, 129 Traumatic mydriasis, 122
Trichiasis (ingrowing lashes), 14, 15, 33–4
eyelid infections, 151–2 Tropicamide, 105, 107, 190
Tumors
basal cell carcinoma, 160, 161 benign lesions, 153–60
chalazion, 153–8, 154 Cyst of Moll, 159, 160
incision and curettage, 155–7, 158 keratosis (solar/seborrheic),
159–60
papilloma/skin tags, 157, 158, 159 styes, 154, 156–7
chalazion, 153–8, 154
incision and curettage, 155–7, 158 conjunctival lesions/cysts, 162, 163,
164, 165
Cyst of Moll, 159, 160
diffuse cell basal cell carcinoma, 161 eye surface, 162–5
conjunctival lesions/cysts, 162,
163, 164, 165
red, painful and irritable lesions, 165
eyelids
benign lesions, 153–60 malignant lesions, 160–2
internal ocular iris, 165–6
retina/choroid, 166–7 iris, 165–6
keratosis (solar/seborrheic), 159–60 lacrimal sac lesions, 168–9 malignant lesions, 153, 160–2,
163
basal cell carcinoma, 160, 161 melanoma, 162, 163, 166–7 sebaceous cell carcinoma, 153,
162
squamous cell carcinoma, 161,
162
malignant melanoma, 162, 163, 166–7
management/referral, 163, 164 non-inflamed/non-tender mass, 169 non-pigmented lesions
eye surface, 164 iris, 166
papilloma/skin tags, 157, 158, 159 periorbital/orbital, 167–9 pigmented lesions
eye surface, 162–3 iris, 165–6
proptosis, 167–8 pterygium, 164 retina/choroid, 166–7 retinoblastoma, 8, 167
sebaceous cell carcinoma, 153, 162 secondary metastases, 167 squamous cell carcinoma, 161, 162
Index 211
Upper respiratory tract infections, 147 keratoconjunctivitis, 45, 52
Uveitis acute, 23
anterior chamber, 14, 16, 22 examination, 22, 23 features, 35
painful eye, 66
and photophobia, 18, 21 pitfalls, 35
previous, 19
red eye, 14, 16, 18, 19, 21, 22, 23, 35 referral/follow up, 35
Valsalva maneuver, 55, 84 Vexol (rimexolone), 188 Viral infections, 45, 65 Viscotears (lubricant), 190
dry eye, 63, 135 keratoconjunctivitis, 52
Vision
acute partial loss, 80–91 branch retinal vein occlusion
(BRVO), 81, 82, 83
central retinal vein occlusion (CRVO), 81, 82, 83
macular hemorrhage, 83–4 migraine see Migraine myopic correction, 87 optic neuritis (ON), 88–90 retinal detachment, 86–8
vitreous hemorrhage, 84, 85, 86 acute total loss, 73–9
central retinal artery occlusion, 76–8
functional loss, 79–80 occipital infarct, 78–9 optic nerve infarction, 74–5 temporal arteritis, 75
blurred, glaucoma surgery, 182 central visual loss, 104–5 chronic loss, 91–104
amblyopia, toxic or nutritional, 103–4
cataracts see Cataracts diabetic
retinopathy/maculopathy, 81, 92, 100–1, 103
glaucoma, 95–8 hydrops, 92 keratonconus, 92
macular degeneration, agerelated, 98–100
spectacles, old, 65, 102–3 distorted, 91 documentation, 3–5
double see Diplopia (double vision) functional loss, 79–80 loss/reduction, 73–106
acute partial loss, 80–91 acute total loss, 73–9 central visual loss, 104–5 chronic loss, 91–104 eyelid infection, 149 functional loss, 79–80 profound loss, 84 transient loss, 105–6
normal, 3 profound loss, 84
subnormal see Subnormal vision transient loss, 105–6
Visual acuity (VA), 2–5 blunt injuries, 118 chart, 3
reading, 4 functional loss, 79 painful eye, 65 pinhole, 2, 5
red eye, 20, 46, 55, 59 sharp/penetrating injuries, 128
Visual fields examination, 10–12, 47 loss patterns, 10
hypertension related, 74 Visual symptoms, 73–111
see also Diplopia (double vision); Vision
astigmatism, 175
’cobwebs’ (floaters, flashes), 106 flashes, 106
floaters, 81, 106–7
hypermetropia (long sightedness), 175
loss/reduction in vision, 73–106 myopia, 175
Vitreous hemorrhage associations, 84 examination/management, 86 features, 84
flashes, floaters or cobwebs, 107 fundus, 8
partial vision loss, 84, 85, 86 pitfalls, 86
red reflex, 8 referral/follow up, 86 visual field loss patterns, 10
Voltarol (anti-inflammatory drops), episcleritis, 43, 58
Watering eye, 132–8
see also Painful eye; Red eye acute, 132
212 |
|
|
Index |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Watering eye contd |
|
Xalatan (latanoprost) |
|
|
|
||||||||||||||||||||||
|
|
|
|
|
|
||||||||||||||||||||||||
|
|
|
|
|
|
||||||||||||||||||||||||
|
|
|
|
||||||||||||||||||||||||||
|
|
|
adult management/referral, 132, |
|
|
allergies, 50 |
|
|
|
||||||||||||||||||||
|
|
|
|
||||||||||||||||||||||||||
|
|
|
133–7 |
|
|
glaucoma, 189, 195 |
|
|
|
||||||||||||||||||||
|
|
|
allergy, 144 |
|
|
shingles, 44 |
|
|
|
||||||||||||||||||||
|
|
|
child management/referral, 132, 138 |
|
Xylometazoline hydrochloride (allergy |
|
|
|
|||||||||||||||||||||
|
|
|
chronic, 132–3 |
|
|
|
drops), 50, 145, 188 |
|
|
|
|||||||||||||||||||
|
|
|
common causes, 133 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
ectropion, 132, 133, 134 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
examination, 133 |
|
YAG laser, 94, 101, 184 |
|
|
|
|||||||||||||||||||||
|
|
|
main causes, 132 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
management/referral, 133–5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
Welding, injury from, 18, 45, 48–9 |
|
Zoton (lansoprazole), 54, 75 |
|
|
|
||||||||||||||||||||||
|
|
|
|
||||||||||||||||||||||||||
|
|
White pupil reflex, 8 |
|
Zovirax ointment, 187, 194 |
|
|
|
||||||||||||||||||||||
|
|
|
|
||||||||||||||||||||||||||
|
|
Wound dehiscence, 174 |
|
|
illustrated, 188 |
|
|
|
|||||||||||||||||||||
|
|
|
|
||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
keratoconjunctivitis, 52 |
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shingles, 44, 149 |
|
|
|
|||||||||||
|
|
X-rays |
|
|
ulcers, contact-lens-related, 40 |
|
|
|
|||||||||||||||||||||
|
|
|
hammering injuries, 131 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
sharp and penetrating injuries, 128 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
